68 Neoadjuvant MIP (mitomycin C+ ifosfamide + cisplatin) chemotherapy for non metastatic unresectable non small cell lung cancer (NSCLC): Are there prognostic factors for response obtention after three courses?
Paesmans, M., Sculier, J.P., Giner, V., Bureau, G., Lafitte, J.J., Ninane, V., Thiriaux, J., Van Cutsem, O., Mommen, P., Van Houtte, P., Klastersky, J.Volume:
18
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/S0169-5002(97)89347-6
Date:
August, 1997
File:
PDF, 299 KB
english, 1997